Virtual alcohol use disorder treatment company Ria Health completed an $18 million Series A funding round led by SV Health Investors.
Other participants in the round include SV limited partners, BPEA Private Equity and previous investor SOSV.
WHAT IT DOES
Ria provides virtual care for alcohol use disorder, including medication-assisted treatment like naltrexone, acamprosate and gabapentin that...
Mental health benefits provider Lyra Health announced new tools to help customers address suicidality, alcohol use disorder and other complex care needs.
The new tools will be available at the beginning of 2022. Lyra Reset, a treatment program for alcoholism, uses virtual therapy, group sessions, symptom assessments, peer support, digital lessons that teach coping skills and medication for...
The online alcohol treatment platform Monument closed its $10.3 million Series A funding round Wednesday that was led by San Francisco-based VMG Catalyst.
With the completion of this round, Monument has raised a total of $17.8 million since its launch last May.
WHAT IT DOES
Monument was born out of cofounder and CEO Mike Russell’s journey with an alcohol use disorder.
After years of having an “...
Swedish pharmaceutical and digital therapeutic company Orexo has launched its digital solution for alcohol use disorder, vorvida, through the help of Accenture’s INTIENT Patient platform.
The INTIENT Patient platform, which is powered by Google Cloud, supports vorvida’s virtual cognitive behavioral therapy services by providing secure data storage and artificial intelligence-enabled analytics.
"...
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.
The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...
For people going through addiction treatment, relapses can happen at any time. So, operating off the notion that close monitoring could offer more opportunities for early intervention, two health technology companies are working to leverage remote patient monitoring to offer better care to people with alcohol use disorder.
Soberlink, makers of a high-tech, FDA-cleared remote breathalyzer, will...
